Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cytosorbents (CTSO) Inventory Average (2016 - 2025)

Historic Inventory Average for Cytosorbents (CTSO) over the last 14 years, with Q3 2025 value amounting to $3.9 million.

  • Cytosorbents' Inventory Average rose 194.98% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year increase of 194.98%. This contributed to the annual value of $3.1 million for FY2024, which is 1065.59% down from last year.
  • Latest data reveals that Cytosorbents reported Inventory Average of $3.9 million as of Q3 2025, which was up 194.98% from $3.4 million recorded in Q2 2025.
  • Over the past 5 years, Cytosorbents' Inventory Average peaked at $5.2 million during Q2 2022, and registered a low of $1.9 million during Q2 2023.
  • In the last 5 years, Cytosorbents' Inventory Average had a median value of $3.5 million in 2022 and averaged $3.6 million.
  • In the last 5 years, Cytosorbents' Inventory Average plummeted by 6382.41% in 2023 and then surged by 11358.03% in 2024.
  • Over the past 5 years, Cytosorbents' Inventory Average (Quarter) stood at $4.6 million in 2021, then dropped by 24.65% to $3.5 million in 2022, then dropped by 9.28% to $3.2 million in 2023, then dropped by 5.86% to $3.0 million in 2024, then increased by 28.95% to $3.9 million in 2025.
  • Its last three reported values are $3.9 million in Q3 2025, $3.4 million for Q2 2025, and $2.9 million during Q1 2025.